Literature DB >> 23804073

Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.

Hui Yang1, Xianghui Wang, Yan Zhang, Huanrong Liu, Jiongbo Liao, Kun Shao, Yiwei Chu, Guangwei Liu.   

Abstract

The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase which has a central role in the regulation of cell growth and metabolism. In the study of the mTOR signaling pathway, tuberous sclerosis complex (TSC) 1/2 complex is identified as a critical regulator of mTOR activity. TSC1/2 plays important roles for immune cell homeostasis and differentiation by negative control of mTOR signaling pathway. TSC1/2-mTOR pathway is proving to be a central point in regulating immune function of diverse immune cells. In this review, we discuss the function of TSC1/2-mTOR to direct the innate and adaptive immune cell development and function. Furthermore, we focus on the role of TSC1/2-mTOR signaling pathway in immune cell mediated diseases, especially autoimmunity.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23804073     DOI: 10.1002/jcp.24426

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report.

Authors:  M Flader; P Kurzawa; J Maldyk; J Sygut; J Harasymczuk; A Kropinska; D Handkiewicz-Junak; B Jarzab; K Kotulska; M Niedziela
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

2.  Evidence for the link between defective autophagy and inflammation in peripheral blood mononuclear cells of type 2 diabetic patients.

Authors:  Samira Alizadeh; Hossein Mazloom; Asie Sadeghi; Solaleh Emamgholipour; Abolfazl Golestani; Farshid Noorbakhsh; Mohsen Khoshniatnikoo; Reza Meshkani
Journal:  J Physiol Biochem       Date:  2018-04-13       Impact factor: 4.158

Review 3.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

Review 4.  Intersection of mTOR and STAT signaling in immunity.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Trends Immunol       Date:  2014-11-15       Impact factor: 16.687

Review 5.  Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy.

Authors:  Adrian M Eiden; Shuling Zhang; Joy M Gary; John K Simmons; Beverly A Mock
Journal:  Clin Cancer Res       Date:  2015-11-25       Impact factor: 12.531

6.  Medicinal Plant Leaf Extract From Sage and Lemon Verbena Promotes Intestinal Immunity and Barrier Function in Gilthead Seabream (Sparus aurata).

Authors:  Ricardo Salomón; Felipe E Reyes-López; Lluis Tort; Joana P Firmino; Carmen Sarasquete; Juan B Ortiz-Delgado; José C Quintela; José M Pinilla-Rosas; Eva Vallejos-Vidal; Enric Gisbert
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

7.  Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis.

Authors:  Guang Yang; Lu Yang; Xiaofan Yang; Xiuyu Shi; Jing Wang; Yujie Liu; Jun Ju; Liping Zou
Journal:  Exp Ther Med       Date:  2014-11-27       Impact factor: 2.447

8.  Cord Blood Cells Responses to IL2, IL7 and IL15 Cytokines for mTOR Expression.

Authors:  Anahita Mohammadian; Elahe Naderali; Seyedeh Momeneh Mohammadi; Aliakbar Movasaghpour; Behnaz Valipour; Mohammad Nouri; Hojjatollah Nozad Charoudeh
Journal:  Adv Pharm Bull       Date:  2017-04-13

9.  Extremely Preterm Infant Born to a Mother With Severe COVID-19 Pneumonia.

Authors:  Molly C Easterlin; Theodore De Beritto; Amy M Yeh; Fiona B Wertheimer; Rangasamy Ramanathan
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

10.  Identification of the novel interacting partners of the mammalian target of rapamycin complex 1 in human CCRF-CEM and HEK293 cells.

Authors:  Hazir Rahman; Muhammad Qasim; Michael Oellerich; Abdul R Asif
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.